tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matt Dellatorre, 3 are a HOLD (37.5%), 5 are a BUY (62.5%).
Analyst Matt Dellatorre, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 90% that have a potential upside of 21.76% achieved within 67 days.
Matt Dellatorre’s has documented 16 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TEVA, Teva Pharma Industries Ltd ADR at 09-Feb-2026.
Analyst best performing recommendations are on VTRS (VIATRIS).
The best stock recommendation documented was for VTRS (VIATRIS) at 7/18/2025. The price target of $10 was fulfilled within 27 days with a profit of $1.52 (17.92%) receiving and performance score of 6.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 11-Mar-2024
$47
$7.59 (19.26%)
$42
12 days ago
(15-Oct-2026)
7/9 (77.78%)
$5.89 (14.33%)
140
Buy Since 09-Jul-2025
$50
$10.59 (26.87%)
$35
15 days ago
(12-Oct-2026)
21/23 (91.3%)
$8.9 (21.65%)
454
Buy Since 27-May-2025
$50
$10.59 (26.87%)
$45
1 months 4 days ago
(23-Sep-2026)
3/6 (50%)
$10.99 (28.17%)
134
Buy Since 01-Feb-2024
$48
$8.59 (21.80%)
$42
1 months 23 days ago
(04-Sep-2026)
11/13 (84.62%)
$11.64 (32.01%)
184
Buy Since 13-May-2024
$44
$4.59 (11.65%)
$42
2 months 29 days ago
(28-Jul-2026)
22/31 (70.97%)
$12.33 (38.93%)
216
What Year was the first public recommendation made by Matt Dellatorre?
